There is no cure for CKD and so the key is preventing or delaying its progression. The main pharmacological treatments offered to those with CKD are blood pressure and proteinuria control. NICE recommends that atorvastatin 20mg daily is offered to patients with CKD and an eGFR of less than 60mL/min/1.73m2. 

Antiplatelet drugs should be used in CKD for the secondary prevention of cardiovascular disease. It is important, however, to be aware that there is an increased risk of bleeding in patients with CKD. Tight control of hyperglycaemia in diabetes is also important in preventing or delaying CKD progression.

Blood pressure targets in CKD are less than 140/90mmHg, unless the patient has diabetes or proteinuria when a blood pressure of less than 130/80mmHg is aimed for. Additional factors may play a part when giving healthy lifestyle advice to patients with CKD and when using antihypertensives in this group.